We have used 75% t o 90% pure murine erythroid colonyforming units (CFU-E) t o delineate the processes and factors underlying their maturation. These CFU-E form 32 cell colonies and are drawn from what we term generation I of a six-generation long maturation sequence (Landschulz et al, Blood 79:2749, 1992). Applying assays of "Fe-heme biosynthesis and colony numbers as measures of maturation and analyses of DNA degradation as an index of programmed cell death, we find that (1) erythropoietin (Epo) enhances maturation throughout most of its course; (2) Epo first seems able t o forestall DNA degradation when CFU-E reach generation II; (3) the processes that Epo elicits thereafter start t o persist when Epo is withdrawn; (4) insulin-like growth factor I (IGF-I) also forestalls DNA breakdown, but later loses effectiveness; (5) IGF-I adds little t o maturation when Epo levels are high, H E ADVENT OF purificative methods for the prepara-T tion of defined populations of erythroid colonyforming units (CFU-E) has made it possible to delineate the events and factors that underlie CFU-E maturation into red blood cells (RBCs). For example, in a recent report,' we purified two murine CFU-E populations, one producing mainly 32-cell erythroid colonies and the other mainly 16-cell ones. We termed these populations generation I and generation I1 CFU-E, respectively. By measuring erythropoietin (Epo) exposure times necessary to stimulate later 59Fe-heme biosynthesis, we found generation I CFU-E were unresponsive to Epo and only became so when they reached early4 phase of generation 11. Because the appearance of Epo responsiveness in generation I1 CFU-E coincided with the onset of DNA replication, we supposed that events associated with replication were reprogrammed during transit from generation I to I1 and that it was this reprogramming that enabled Epo to act.
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In this report, we extend our studies to later CFU-E maturation. We find that Epo enhances maturation throughout much of erythropoiesis while, at the same time, finding that maturation becomes semi-sustained after CFU-E are exposed to transient Epo pulses. We use this setting to inquire: How much does semi-sustained maturation after Epo pulses depend on persistence of what Epo elicits and how much does it depend on other serum cytokines such as insulin-like growth factor I (IGF-I)?2-7 Finding that Epo and IGF-I each efficiently forestall DNA breakdown beginning in cell generation 11, but also finding that the effects of IGF-I are exerted mainly early and that the lingering effects of what Epo elicits account for most of semi-sustained maturation, we then ask: Are continuously supplied Epo and IGF-I together sufficient to account for all of CFU-E maturation? Finding that this is probably not so even when Epo levels are high and certainly not so when Epo levels lie in the normal range, the unanswered question is: What other factor(s), present in serum, is needed for optimal maturation?
In addressing these questions, we rely in part on serumpoor cultures in which contamination with unwanted enbut when Epo levels are low, enhances it substantially; and (6) for maturation t o be entirely optimal, an unidentified serum factor(s) is probably required when Epo levels are high and is certainly needed when Epo levels are like those in normal animals. Quantitatively, about 40% of optimal in vitro erythropoiesis at normal Epo levels depends on Epo alone, another 30% or less on the addition of IGF-I, and the remaining 30% or more on the addition of unidentified serum factor(s). Applied together, these three or more factors lead t o two-thirds of the maximum maturation realized with saturating Epo levels. Because we also find that heme accumulated in CFU-E culture can closely approach levels in red blood cells, we suppose that our conclusions apply as well t o CFU-E maturation in vivo. o 1992 by The American Society of Hematology.
hancing growth factors is minimized. For assay, we depend mainly on 59Fe-heme biosynthesis rather than on colony enumeration to measure CFU-E maturation, a tactic that reveals otherwise inapparent aspects of response. To some analyses, we apply high-performance liquid chromatography (HPLC)-based estimates of 59Fe-heme-specific activity so that moles of heme produced in response to various treatments can be judged against what a mouse accomplishes when it produces RBCs with 14 pg hemoglobin.8 Isolation and purify of CFU-E. Generation I CFU-E' from thiamphenicol-treated anemic mice9 were collected as described1J0J1 in 75% to 90% morphologic purity.' Eighty percent of these formed 2-day erythroid colonies.
Fe-saturated Tf (&65/Am = 0.045) was prepared from apoTf by the nitrilotriacetic acid method,I2 using 59Fe or unlabeled (56Fe) FeC13. After pH 7.6 dialysis versus 0.1 mol/L perchlorate and then versus Hanks' Balanced Salt Solution, 59Fe concentration was estimated by liquid scintillation. Concentration of 59FeTf and 56FeTf, estimated by &5 (0.57 &5 = 10 mg/mL), was expressed as micromoles per liter of monoferric Tf using molecular weights of 39,750 and 36,000 for human and bovine Tf,13 respectively. In CFU-E incubations, micromoles per liter of 59FeTf was estimated from applied radioactivity by reference to specific activity, whereas micromoles per liter of 56FeTf was based on dilution of that in postdialysis stocks. Losses during handling were thus obviated for 59FeTf, but not for 56FeTf.
CFU-E incubations with 59FeTf were performed in 1 mL at 37°C under water-saturated 5% COz using 16 x 110 mm flat-sided culture tubes. Applied cells were recurrently monitored by Coulter (Hialeah, FL) count. Seeded CFU-E, the product of the Coulter estimate and the percentage that formed colonies, were s30,000/tube, the upper bound (data not shown) for linearity (Fig 1) between seeded CFU-E and heme biosynthesis. Tubes were incubated on their flat sides, a geometry leading to 1.1 to 1.2 times more heme biosynthesis than when upright. After 42 hours of incubation, carrier RBCs were added, the cells were washed twice, and 59Fe-heme was assayed by liquid scintillation of cyclohexanone extracts of acid cyanmetheme.'J4 Serum-rich media. Media contained 32% decomplemented (56°C for 30 minutes) FBS,I5 Epo and/or IGF-I as later noted, 1% AlbuMAXI BSA, 55 pmol/L 2-mercaptoethanol (2-ME), 100 U/mL penicillin, and 100 pg/mL streptomycin in a-minimal essential medium (aMEM)/NaHCO3/10 mmol/L HEPES, pH 7.4. The single lot of FBS (Hyclone) used throughout contained 1.79 mg/L serum Fe and thus 32 pmol/L monoferric Tf.
Media lacked added FBS and contained Epo and/or IGF-I as later noted; human FeTf in the 1 to 3 pnol/L range, except as indicated; Iscove's modified Dulbecco's medium (IMDM)/NaHC03I6; 2-ME and antibiotics at the same levels as in serum media; and lipid concentrations similar to those established by Iscove et all6 and Stewart et aI,l7 ie, 5.6 Fg/mL oleic acid, 7.7 pg/mL cholesterol, and 7.9 p,g/mL L-a-phosphatidylcholine dipalmitoyl. Lipid preparation followed reported methods.I7 In keeping with prior r e p o r t~,~J~J~ serum-poor media also contained Fe-Tfpreparation.
CFU-E incubations.
Serum-poor media.
1% BSA. However, we substituted a chromatographically isolated lipidated BSA preparation (AlbuMAXI; GIBCO BRL) for the delipidated BSA preparations applied by others.6.16 The rationale for this substitution lay with the effects of increasing BSA concentration on CFU-E maturation in serum-poor media. In the 5 to 20 mg/mL range, increasing levels of delipidated Cohn fraction V BSA reportedly led to 1.5-fold increases in CFU-E colony numwhereas increasing levels of the first batch of AlbuMAXI BSA tested had no effect when 59Fe-heme biosynthesis was used as the index of CFU-E maturation (Fig 2) . Because we also found that increasing levels of deionized,I6 but still lipidated, Cohn fraction V BSA (cat. no. A4503; Sigma) typically led to increasing and then decreasing heme biosynthesis (Fig 2) , we reasoned that such BSA is contaminated with both erythropoietic enhancers and inhibitors, that inhibitors seem to be preferentially removed during BSA delipidation: and that enhancers seem to be preferentially removed during preparation of lipidated AlbuMAXI BSA (Fig 2) . In a second lot of AlbuMAXI BSA tested (Fig 2) , the relative proportion of enhancers was apparently still further lessened because 59Fe-heme synthesized consistently decreased as BSA concentration increased. Consequently, because we especially wished to examine the effects of added growth factors in settings in which contaminant enhancers were minimized, we chose Albu-MAXI as the source of BSA used for serum-poor media.
Filter-sterilized, 6.5-~mol/L IGF-1 aliquots stored at -85°C were prepared by resuspending supplied solids in 10 mmol/L Na acetate and diluting them with an equal volume of 1% AlbuMAXMMDM.
When DPM of 59Fe-heme synthesized by CFU-E was to be expressed as
IGF-I.
Estimation of 59Fe-heme-specific activiy via HPLC assay. (emM = 117). After assaying net DPM in heme fractions of radioactive samples by liquid scintillation, 59Fe-heme disintegrations per minute (DPM)/pmol from replicate incubations were estimated with 4% average coefficient of variation (CV).
In Table 1 , purified bovine FeTf supported heme biosynthesis only 9% to 18% as well as purified human FeTf. A like limitation applies to FeTf from FBS, for which we calculate, after HPLC assay of 59Fe-heme-specific activity in murine CFU-E incubations, that bovine serum FeTf has 9.5% the effectiveness of human FeTf (data not shown). Accordingly, we used only human FeTf in our studies and assumed that when FBS was added as a growth factor source that it contributed only 9.5% of its FeTf in a functionally effective form.
Compensation for FeTfconcentration. When heme accumulated in CFU-E cultures with suboptimal FeTf was to be compared with RBC heme accumulated in vivo, where FeTf was presumably optimal, we referred to standard plots of picomoles of heme synthesized per 104 CFU-E versus applied micromoles per liter of FeTf (Fig 3) To assess factors influencing Epo response throughout CFU-E maturation, we compared effects of Epo subtraction in serum-rich incubations with those in serumpoor ones. Here, CFU-E were first grown with 1 U/mL Epo in either 32% FBS media (0.9 pmol/L effective bovine FeTf) or serum-poor media (1.6 wmol/L 56FeTf). After 0 to 22.5 hours of Selection of FeTf source.
Epo subtraction experiments.
incubation at 3 7 T , cells were recovered, washed three times; dispersed; enumerated; reseeded, with Coulter monitoring, into final 1 mLvolumes; and reincubated at 37°C within 100 minutes. At each time point, cells initially grown in serum media were reincubated in tubes with serum media: three with 1 U/mL Epo (control tubes) and three without Epo (subtracted tubes). Similarly, cells initially grown serum-poor were reseeded in tubes with serum-poor media: three with 1 U/mL Epo (controls); three without Epo (subtracted tubes); and, except for the 0-hour subtraction, three without Epo but with 4 nmol/L IGF-I (subtracted tubes plus IGF-I). 59FeTf was added to all after a total 26 hours of incubation at 3TC, leading to 1.6 pmol/L effective FeTf in serum-rich incubations and 2.3 pmol/L FeTf in serum-poor ones. At 42 hours, cells were harvested for 59Fe-heme and average 59Fe-heme DPM in subtracted tubes expressed as a fraction of control average for the same time point in the same media. Such use of subtracted:control tube ratios minimized nonspecific effects arising from cell washing and transient interruption of incubation at 37°C.' Thus, when the same media were used, it was possible to compare successive time points. So that serum-poor and serum-rich cultures could be compared, we used collateral assays of 59Fe-heme-specific activity and of 26-to 42-hour 59Fe-heme biosynthesis after continuous Epo exposure to estimate picomoles of heme per lo4 CFU-E in serum-depleted 2.3 bmol/L FeTf cultures as a percent of picomoles per lo4 CFU-E in serum-rich 1.6 pmol/L FeTf cultures.
CFU-E (0.5 to 1.8 x 106/mL) that had been preincubated in serum-rich media at 37°C for 4,7, or 14 hours with 1 U/mL Epo or for 14 hours with 30 nmol/L IGF-I were reacted20.21 with 0.3 to 0.5 pCi/mL of methylJH-thymidine (5 Ci/mmol) for 30 minutes at 37°C. Reactions were the same for nonpreincubated CFU-E except that Epo was omitted. After recovery and washing twice, labeled cells were either harvested for baseline DNA analysis or reincubated at 37°C in 1.4 mL serumpoor media, 2 pmol/L FeTf, 20 pmol/L 2'-deoxycytidine, and 20 wmol/L thymidine?I Several sets of tubes were thus reincubated at 37°C. One set contained 1 U/mL Epo, one set lacked it, and, on two occasions, a third set lacked Epo but contained 30 nmol/L IGF-I. For tubes preincubated for 14 hours with IGF-I, two sets were reincubated: one set lacking cytokines and one containing 30 nmol/L IGF-I. After reincubations at 37°C for varying periods, pelleted cells from one tube of each set were lysed with 0.5 mol/L EDTA, pH 8/0.5% Na N-lauroylsarcosine/200 wg/mL proteinase K solution; incubated for 3 hours at 50°C; stored at -80°C; and DNA later purified by successive extractions with phenol and 24:l CHC13:isoamylalcohol solutions. After ethanol precipitation, soluAnalysis of DNA breakdown. For each row, average (?SE) 59Fe-hemespecific activities (third and sixth columns) are based on HPLC assays of duplicate 42-hour CFU-E incubations with 1 U/mL Epo in serum-poor media containing either 59FeTf as the sole Fe source (third column) or a mixture of like nanomoles of 59FeTf with unlabeled "FeTf (sixth column). As noted in Fe-Transferrin Preparation, nanomoles of 59FeTf (second column) are accurately known from applied radioactivity, whereas nanomoles of "FeTf (fifth column) do not allow for losses during handling. We use data in rows one and two to calculate relative "Fe incorporation (eighth column), thereby estimating the fraction of each 56FeTf that survives loss. Thus aided, we apply these estimates in rows three and four to calculate relative incorporation of 59Fe (seventh column) and SFe (eighth column), thereby leading to the estimated efficacy with which bovine and human FeTf donate Fe to murine CFU-E (ninth column). Consequently, after canceling terms: in the first row where 354 (7. Epo. Each vertical axis value is based on 3-replicate assays of SsFe-heme DPM synthesized per l W CFU-E seeded, expressed as average f SE heme picomoles per 1W CFU-E using corresponding 2-replicate average =Fe-heme DPM/ pmol (inset) from HPLC assay. Horizontal axis values reflect total FeTf corrected (Table 1) for MFeTf losses during handling.
bilized DNA (104 to lo5 CPM) in 12.5% sucrose/30 mmol/L NaOH/2 mmol/L EDTA was applied in alternate lanes to 1% agarose gels prepared in 20 mmol/L NaC1/2 mmol/L EDTA and, before sample application, exposed to 30 minutes of electrophoresis in 30 mmol/L NaOH/2 mmol/L EDTA running buffer.zz,u After 20 V overnight electrophoresis and ethidium Br staining, approximately 27 5-mm slices were excised from each lane, placed in vials with 1 mL 0.2N HC1, autoclaved (100°C for 5 minutes), and assayed by liquid scintillation. Taking the average CPM in the proximal two to three gel slices as background, net CPM from the next three slices were considered to be high molecular weight DNA by reference to Hind111 digests of ADNA and expressed as a percentage of total net CPM found for all slices. In evely case, the degree of tritiated DNA fragmentation into multiples of nucleosome-sized fragments was consistent with that less exactly evident in stained gels.
RESULTS
The prolonged effect of Epo: Mechanisms for semi-sustained CFU-E maturation after Epopulses. Epo subtraction experiments in serum-rich media (Fig 4, W) 
exposure was limited to the first 8 hours. It follows that 2-cell colonies formed after 8 hours of Epo exposure somehow progressed to the &cell stage of what would have been a 32-cell colony' had Epo been continuously supplied. A like conclusion emerged when CFU-E were preincubated with 1 U/mL Epo for 7 hours and then, after washing and dispersing 2-cell colonies, seeded into serum-bearing methylcellulose and scored microscopically 2 days later (Table 2 ). When grown with Epo, such CFU-E average 16 cells per colony.' When grown without Epo, the percentage of CFU-E forming 24-cell colonies was two-thirds of that found in Epo-bearing culture, whereas the percentage forming 2 %cell colonies was one-third of the Epo-supported value. Clearly, whether their impact is measured by colony assay (Table 2) or by heme biosynthesis (Fig 4) , 7-or 8-hour high-level Epo pulses enable CFU-E to average several further cell divisions in the later absence of Epo.
The explanation for the maturation sustained after brief Epo exposure cannot lie with residual Epo, because Epo does not linger in CFU-E for even a few hours after it is withdrawn,' let alone through several cell cycles. Nor can semi-sustained maturation be attributed to older, less Epo-dependent cells, because such cells form 5 5% of our CFU-E preparations.' Therefore, the mechanisms by which Epo pulses lead to semi-sustained maturation must depend on a combination of (1) intrinsic events, ie, persistence of the processes that Epo elicits; and (2), in FBS cultures, effects of serum growth factors such as IGF-L3 The relative contributions of these intrinsic and extrinsic effects are examined in Fig 4, using a method of normalized ratios between subtracted and control tubes to compare samples drawn from separate preincubations (see Materials and Methods and the legend to Fig 4) . While this approach precludes direct statistical comparisons of responses in serum-poor cultures with those containing FBS, it is reliable to the extent that coefficients of variation are small for each component in each ratio. Because this was universally true (see legend to Fig 4) , we presume that our finding that heme biosynthesis after Epo pulses in serum-poor culture is always at least two-thirds of that in FBS means that most semi-sustained maturation arises from what Epo elicits rather than from what serum provides. Within this same analytic framework, it is also evident in Fig 4 that , when IGF-I is supplied at a 4 nmol/L level like that in 30% FBS? its effects vary with time. IGF-I is superior to serum when Epo is never supplied, is a good serum substitute when Epo is subtracted after only 7.5 hours, but is an incomplete Based on scores of three 32% FBS-bearing methylcellulose plates for each condition. Based on scores in four to five individual methylcellulose plates under each set of conditions, except for the bottom row, in which only one plate was examined.
Abbreviation: SP, serum-poor media.
substitute when Epo is withdrawn at 15 and 22.5 hours. The inferences are that IGF-I acts mainly early and that a portion of semi-sustained maturation depends on something more than IGF-I. Support for this idea that IGF-I acts mainly early appears in Table 3 , where high levels of continuously applied IGF-I lead to just as many colonies as high levels of Epo, but the colonies are undersized. IGF-Idriven CFU-E thus survive, but stop dividing prematurely. Effects of Epo and IGF-I on DNA breakdown in CFU-E. To assess the mechanisms by which Epo pulses lead to semi-sustained maturation and by which IGF-I promotes maturation, we examined the capacity of each to forestall DNA breakdown in CFU-E cultured in serum-poor media.
As seen in Fig 5, four findings emerge.
First, modest DNA degradation in CFU-E occurs even in the presence of Epo, a result consistent with the idea that Epo forestalls but does not preclude apoptosis, ie, programmed cell death.20, 21, 25 Second, in minus-Epo cultures, DNA breakdown develops later in CFU-E that were labeled and assayed directly after harvest than it does in CFU-E that were first preincubated with Epo for 4 hours before labeling and assaying. In Fig SA and D, in which 4 hours of preincubation was omitted and cells lie in CFU-E generation I at the start of assay,' the slope for the DNA breakdown in minus-Epo cultures extrapolates, when omitting the zero-time point, to onset at 2.5 hours after beginning pulse-labeling in the absence of Epo. In contrast, in Fig 5B, in which CFU-E lie in cell generation I1 after 4 hours of preincubation with Epo,' the slope of the breakdown extrapolates to the start of breakdown assay even though Epo was present during DNA labeling. Similar results were seen when DNA degradation was assessed for CFU-E incubated in 32% FBS rather than in serum-poor media. As in Fig SA and D, the onset of the breakdown was delayed 2.5 hours in nonpreincubated CFU-E, but, like Fig 5B, much less delayed in CFU-E that had already progressed to the start of S-phase in generation 11' by the time the breakdown assay was initiated (data not shown). Thus, all findings are consistent with our report' that Epo response only begins when CFU-E attain S-phase of generation 11. Combining past and present findings, we now suppose that this is the time when an e n d o n~c l e a s e~~J~ is either activated or not otherwise suppressed. Third, the pattern of DNA breakdown in minus-Epo cultures changes when CFU-E are preincubated with Epo for 7 hours (Fig 5C and E) or 14 hours (Fig 5F) . Because CFU-E have by then advanced well into the time when Epo can act and when processes that it elicits can perhaps reach full fruition and because the breakdown in the absence of further Epo is now either attenuated (Fig 5C and F) or much delayed (Fig 5E) , we presume that the processes that Epo elicited have begun to persist. Analogous findings are reported by Koury and Bondurant,21 who depict no delay in the breakdown in FVA cells, which roughly correspond to generation I1 CFU-E,lJ1 but depict substantial delays in basophilic erythroblasts and proerythroblasts taken from Epo-rich animals.
Fourth, applying doses of IGF-I and Epo that maximize their effects on colony growth,*s3 30 nmol/L IGF-I initially retards DNA breakdown just as well as 1 U/mL Epo (0.1 nmol/L) (Fig 5A and B) and, in this way, contributes to semi-sustained maturation seen after Epo is withdrawn (Fig 4) . However, in Fig 6, IGF-I later loses effectiveness, a result in keeping with Fig 4 and Table 3 .
The upshot is that semi-sustained CFU-E maturation might entirely arise from the persistence of processes that attenuate DNA breakdown, processes that seem to begin in CFU-E cell generation I1 and that thereafter continue to be elicited after Epo exposure, but not so persistently after IGF-I exposure.
What growth factors are needed for optimal CFU-E maturation? What is missing in most studies of CFU-E matura- 
in culture is an authentic standard against which the effects of additives such as Epo and IGF-I can be judged. To construct such a standard, we applied prior findings that CFU-E each average 32 progeny in 1 U/mL Epo serum culture,' that these complete heme biosynthesis by about 66 hours, and that 80% of such biosynthesis is realized by the end of 42 hours (data not shown). We reasoned that, if in vitro maturation faithfully reflects that in vivo, heme accumulated in vitro should reflect RBC contents that, in BALB/c mice, average 14 pg hemoglobins and thus 5.3 X los heme molecules. Consequently, when in vitro conditions are optimal, the progeny of lo4 CFU-E should accumulate (32) (0.8) (5.3 X los) (lo4) = 1.4 x 1014 heme molecules, ie, 230 pmol, after 42 hours of culture.
With an in vivo-based standard thus set, we asked whether high levels of Epo and IGF-I are all that are required for optimal CFU-E maturation, as others suggest6; or, as inferred from Fig 4, whether another growth factor(s) is needed. We also asked: How much do the effects of IGF-I and other factors depend on the Epo level? In particular, what growth factors are required for optimal maturation when Epo levels are about 10 mU/mL, as they usually are in normal animals? 28 Answers to these questions appear in Fig 3) rather than at the lesser levels that, for economy, were actually used. In this setting, five findings emerge. First, when 1 U/mL Epo is supplied, heme biosynthesis attained without further additions always lies within 85% of the in vitro maximum (Fig 7, circle plots) . While such results might suggest that Epo by itself is nearly sufficient for optimal CFU-E maturation in vitro, the average 150 pmol found for the solid circles (Fig 7A, B , and D) when 1 U/mL Epo acts alone in serum-depleted culture is well short of the 230 pmol set by the in vivo-based standard. Indeed, even when corrected for average 10% heme losses that ensue during cell recovery and heme extraction (data not shown), the effect of 1 U/mL Epo by itself attains only 70% of the expected in vivo level. When nondialyzed 5% to 10% FBS is added to these Epo-rich cultures, peak synthesis averages 170 pmol of heme before correction for losses and 190 pmol afterwards. It might have been even higher if, as the sharply decreasing responses seen at higher serum levels suggest is possible (Fig 7D) , peak responses to serum had not been undercut by inhibitors, eg, those contaminating AlbuMAXI BSA preparations (Fig 2) . Thus, in vitro heme accumulation can closely approach in vivo expectation and, set against such standards, the idea that high levels of Epo are alone sufficient for CFU-E maturation becomes problematic.
Second, the notion6 that high levels of Epo and IGF-I are For personal use only. on October 22, 2017 . by guest www.bloodjournal.org From together sufficient for maximal in vitro maturation is unlikely because 10 to 20 nmol/L IGF-I (Fig 7, triangles) adds little to the effect of high-level Epo acting alone. This outcome is consistent with IGF-I dose-response curves seen in Fig 8, in which IGF-I has its greatest relative effect when Epo is absent, a lesser effect when Epo is low, but little effect when Epo is high.
Third, serum factors augment heme biosynthesis much more when Epo levels are low than when they are high. In Fig 7, the disparity between the effect of 10 mU/mL Epo acting alone and that seen with 5% FBS is substantially greater than the equivalent disparity in the 1 U/mL series.
Fourth, IGF-I only partially substitutes for serum in 10 mU/mL Epo incubations (Fig 7, diamond symbols) , a result like that inferred from Epo subtraction at later times ( Fig   Fifth, while the identity of the serum factor(s) needed for optimal CFU-E maturation is unknown, it seems in Fig 7C to be mostly nondialyzable through a membrane that excludes 14-Kd molecules.
Finally, to assign percentage weight to the contributions of Epo, IGF-I, and unidentified serum factors to CFU-E 4). maturation, we compared the separate and combined effects of 13 nmol/L IGF-I and 5% FBS in cultures with normal (10 mU/mL) and saturating (1 U/mL) Epo levels.
As seen in Fig 9, 
DISCUSSION
Contrasts with prior reports. Our central findings are that Epo acts throughout most of CFU-E maturation; that the still unknown processes by which Epo forestalls DNA breakdown in CFU-E persist once they are well begun; that IGF-I, while it also effectively forestalls DNA breakdown, later loses effectiveness and adds little when Epo levels are high; and, finally, that Epo-driven maturation requires something more than IGF-I to become optimal when Epo levels are normal. By contrast, most prior studies assign a more important maturational role to IGF-I. For example, IGF-I increased human CFU-E proliferation in Epo-rich culture 1.4-to 2.6-fold4-' and murine CFU-E proliferation twofold.4 In minus-Epo cultures, reported IGF-I effects were variable: no effect being found for human CFU-E,6 whereas effects on murine CFU-E ranged from 5%4 to Some of the reasons why our findings differ from those of others probably lie with differences in CFU-E, media, and/or assays used. Unlike our studies, most prior studies used unpurified CFU-E and thus left open the possibility that effects of cytokines such as IGF-I were indirectly mediated. Only Sawada et a1,6 who used 30% to 60% pure human CFU-E and applied limiting dilution analysis, exclude this possibility. In terms of media, two prior reports describe 1 9 to 3-fold4 augmentation of CFU-E maturation when BSA concentration was increased from 0.5% to 2%. Because no such augmentation occurred with the AlbuMAXI BSA (Fig 2) that we used, it is likely that BSA in prior studies was contaminated with erythropoietic inducers. If so, the efficiency of CFU-E maturation was inflated and the need for additional factors might have gone unrecognized. Finally, past studies depended on colony enumeration to assay CFU-E maturation. In contrast, we relied on heme biosynthetic assays that measure the aggregate of CFU-E survival, proliferation, and differentiation. Consequently, except where efforts were made to assess cells per colony,6 past studies neglect proliferation and differentiation occurring after colonies reached scorable size. (Fig 6) , when the effect of IGF-I is on the wane. Candidate factors that may substitute for serum and enhance Epo-driven CFU-E maturation. Factors that might augment CFU-E maturation beyond that attainable with Epo and IGF-I include cloned cytokines such as activin A, which induces hemoglobin accumulation in K562 cells and potentiates Epo-driven proliferation of human CFU-EJ1; atrial natriuretic factor, which augments Epo responses of human CFU-E even when accessory cells are removed32; and erythroid-potentiating activity, which stimulates K562 cell growth and apparently that of CFU-E as well.3J To be added to these are the partially purified proliferative factors for CFU-E described by Fagg and Roitsch,M by Udupa and Lipschitz?' and most recently by Arnaud et aLJ6 Less attractive candidates are those whose role is disputed, eg, those that reportedly influenced colony formation by unpurified CFU-E,37-39 but had no effect on colonies formed from purified human CFU-E in serum-poor culture." Those in such dispute include hydrocorti~one,3~ triiodothyronine," and platelet-derived growth factor.39 In fact, we find that none of these have other than mildly inhibitory effects on heme biosynthesis by purified murine CFU-E in either 10 mU/mL Epo or 1 U/mL serum-poor culture (S.H.
Boyer, unpublished studies). Thus, like Sawada et al," we suppose that the reported effects of these may have been indirectly mediated via contaminants in impure cell preparations. In further unpublished studies, we also support the finding that IGF-11, while it augments CFU-E maturation in the absence of IGF-I, is simply substitutive for it.6 Indeed, as it stands, we have not yet examined a candidate that can replace serum and is additive to both Epo and IGF-I.
